Summary & Overview
CPT 96570: Photodynamic Therapy During Endoscopy or Bronchoscopy
CPT code 96570 represents photodynamic therapy administered to abnormal tissue during the same session as a primary endoscopy or bronchoscopy to destroy cancerous or precancerous cells. This adjunctive, procedure-based therapy combines a photosensitizing agent with controlled light exposure and is used when lesions are accessible via endoscopic or bronchoscopic approaches. Nationally, the code matters for facilities and providers that deliver endoscopic oncology interventions and for payers that manage coverage for adjunctive cancer therapies.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and coding scope, typical sites of service, common modifiers and billing considerations, and where to look for related codes and documentation needs. The publication also summarizes benchmarks and policy-relevant items when available and identifies gaps labeled as "Data not available in the input" when specific payer policies, related ICD-10 diagnoses, taxonomies, or service-line allocations are not provided in the source data.
This brief equips coding professionals, revenue cycle managers, and clinical leaders with a concise reference to the clinical intent of CPT code 96570, expected service settings, and the payer landscape covered in the analysis.
Billing Code Overview
CPT code 96570 describes photodynamic therapy in which a provider administers a photosensitizing drug to abnormal tissue and exposes the area to a specific wavelength of light for approximately 30 minutes to destroy cancerous or precancerous cells. The procedure is performed during the same session as a primary endoscopy or bronchoscopy and is intended for targeted destruction of lesions reachable via the endoscope.
-
Service type: Photodynamic therapy performed as an adjunctive procedure during endoscopy or bronchoscopy
-
Typical site of service: Hospital-based endoscopy or bronchoscopy suite, ambulatory surgery center, or other procedural settings where endoscopy/bronchoscopy is performed
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of smoking presents with hemoptysis and a suspicious endobronchial lesion seen on chest imaging. During a diagnostic bronchoscopy the pulmonologist visualizes a superficial, precancerous or early-stage malignant lesion of the central airways. The provider administers a photosensitizing agent topically or systemically and then performs photodynamic therapy during the same bronchoscopy session to destroy dysplastic or early malignant tissue. The procedure typically occurs in an endoscopy or bronchoscopy suite, ambulatory surgery center, or hospital operating room under monitored anesthesia care or general anesthesia depending on airway management needs. The clinical workflow includes pre-procedure informed consent and assessment, administration of the photosensitizing drug, endoscopic illumination of the lesion for the specified exposure time (approximately 30 minutes depending on tissue depth), immediate post-procedure airway assessment, and short-term observation for phototoxicity, airway edema, bleeding, or respiratory complications prior to discharge or admission for observation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Service furnished under a fee schedule or other payment arrangement (payer-specific) | Use per payer direction when claim processing requires the payer-specific payment indicator modifier. |